Eintrag weiter verarbeiten
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair
Gespeichert in:
Zeitschriftentitel: | Clinical Cancer Research |
---|---|
Personen und Körperschaften: | , , , |
In: | Clinical Cancer Research, 12, 2006, 2, S. 563-568 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Association for Cancer Research (AACR)
|
Schlagwörter: |
author_facet |
Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. |
---|---|
author |
Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. |
spellingShingle |
Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. Clinical Cancer Research DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair Cancer Research Oncology |
author_sort |
lin, xinjian |
spelling |
Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-05-1380 <jats:title>Abstract</jats:title> <jats:p>The mutagenicity of cis-diamminedichloroplatinum(II) (DDP; cisplatin) and the rate at which resistance develops with repeated exposure to DDP are dependent on mutagenic translesional replication across DDP DNA adducts, mediated in part by DNA polymerase ζ, and on the integrity of the DNA mismatch repair (MMR) system. The aim of this study was to determine whether disabling Pol ζ by suppressing expression of its hREV3 subunit in human cancer cells can reduce the mutagenicity of DDP and whether loss of MMR facilitates mutagenic Pol ζ-dependent translesional bypass. The HCT116+ch3 (MMR+/REV3+) and HCT116 (MMR−/REV3+) human colon carcinoma cell lines were engineered to suppress hREV3 mRNA by stable expression of a short hairpin interfering RNA targeted to hREV3. The effect of knocking down REV3 expression was to completely offset the DDP resistance mediated by loss of MMR. Knockdown of REV3 also reduced the mutagenicity of DDP and eliminated the enhanced mutagenicity of DDP observed in the MMR−/REV3+ cells. Similar results were obtained when the ability of the cells to express luciferase from a platinated plasmid was measured. We conclude that Pol ζ plays a central role in the mutagenic bypass of DDP adducts and that the DDP resistance, enhanced mutagenicity, and the increased capacity of MMR−/REV3+ cells to express a gene burdened by DDP adducts are all dependent on the Pol ζ pathway.</jats:p> DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair Clinical Cancer Research |
doi_str_mv |
10.1158/1078-0432.ccr-05-1380 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTEzODA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTEzODA |
institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
imprint |
American Association for Cancer Research (AACR), 2006 |
imprint_str_mv |
American Association for Cancer Research (AACR), 2006 |
issn |
1078-0432 1557-3265 |
issn_str_mv |
1078-0432 1557-3265 |
language |
English |
mega_collection |
American Association for Cancer Research (AACR) (CrossRef) |
match_str |
lin2006dnapolymerasezaccountsforthereducedcytotoxicityandenhancedmutagenicityofcisplatininhumancoloncarcinomacellsthathavelostdnamismatchrepair |
publishDateSort |
2006 |
publisher |
American Association for Cancer Research (AACR) |
recordtype |
ai |
record_format |
ai |
series |
Clinical Cancer Research |
source_id |
49 |
title |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_unstemmed |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_full |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_fullStr |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_full_unstemmed |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_short |
DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_sort |
dna polymerase ζ accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost dna mismatch repair |
topic |
Cancer Research Oncology |
url |
http://dx.doi.org/10.1158/1078-0432.ccr-05-1380 |
publishDate |
2006 |
physical |
563-568 |
description |
<jats:title>Abstract</jats:title>
<jats:p>The mutagenicity of cis-diamminedichloroplatinum(II) (DDP; cisplatin) and the rate at which resistance develops with repeated exposure to DDP are dependent on mutagenic translesional replication across DDP DNA adducts, mediated in part by DNA polymerase ζ, and on the integrity of the DNA mismatch repair (MMR) system. The aim of this study was to determine whether disabling Pol ζ by suppressing expression of its hREV3 subunit in human cancer cells can reduce the mutagenicity of DDP and whether loss of MMR facilitates mutagenic Pol ζ-dependent translesional bypass. The HCT116+ch3 (MMR+/REV3+) and HCT116 (MMR−/REV3+) human colon carcinoma cell lines were engineered to suppress hREV3 mRNA by stable expression of a short hairpin interfering RNA targeted to hREV3. The effect of knocking down REV3 expression was to completely offset the DDP resistance mediated by loss of MMR. Knockdown of REV3 also reduced the mutagenicity of DDP and eliminated the enhanced mutagenicity of DDP observed in the MMR−/REV3+ cells. Similar results were obtained when the ability of the cells to express luciferase from a platinated plasmid was measured. We conclude that Pol ζ plays a central role in the mutagenic bypass of DDP adducts and that the DDP resistance, enhanced mutagenicity, and the increased capacity of MMR−/REV3+ cells to express a gene burdened by DDP adducts are all dependent on the Pol ζ pathway.</jats:p> |
container_issue |
2 |
container_start_page |
563 |
container_title |
Clinical Cancer Research |
container_volume |
12 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792340490883956736 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:04:51.937Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=DNA+Polymerase+%CE%B6+Accounts+for+the+Reduced+Cytotoxicity+and+Enhanced+Mutagenicity+of+Cisplatin+in+Human+Colon+Carcinoma+Cells+That+Have+Lost+DNA+Mismatch+Repair&rft.date=2006-01-15&genre=article&issn=1557-3265&volume=12&issue=2&spage=563&epage=568&pages=563-568&jtitle=Clinical+Cancer+Research&atitle=DNA+Polymerase+%CE%B6+Accounts+for+the+Reduced+Cytotoxicity+and+Enhanced+Mutagenicity+of+Cisplatin+in+Human+Colon+Carcinoma+Cells+That+Have+Lost+DNA+Mismatch+Repair&aulast=Howell&aufirst=Stephen+B.&rft_id=info%3Adoi%2F10.1158%2F1078-0432.ccr-05-1380&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792340490883956736 |
author | Lin, Xinjian, Trang, Julie, Okuda, Tsuyoshi, Howell, Stephen B. |
author_facet | Lin, Xinjian, Trang, Julie, Okuda, Tsuyoshi, Howell, Stephen B., Lin, Xinjian, Trang, Julie, Okuda, Tsuyoshi, Howell, Stephen B. |
author_sort | lin, xinjian |
container_issue | 2 |
container_start_page | 563 |
container_title | Clinical Cancer Research |
container_volume | 12 |
description | <jats:title>Abstract</jats:title> <jats:p>The mutagenicity of cis-diamminedichloroplatinum(II) (DDP; cisplatin) and the rate at which resistance develops with repeated exposure to DDP are dependent on mutagenic translesional replication across DDP DNA adducts, mediated in part by DNA polymerase ζ, and on the integrity of the DNA mismatch repair (MMR) system. The aim of this study was to determine whether disabling Pol ζ by suppressing expression of its hREV3 subunit in human cancer cells can reduce the mutagenicity of DDP and whether loss of MMR facilitates mutagenic Pol ζ-dependent translesional bypass. The HCT116+ch3 (MMR+/REV3+) and HCT116 (MMR−/REV3+) human colon carcinoma cell lines were engineered to suppress hREV3 mRNA by stable expression of a short hairpin interfering RNA targeted to hREV3. The effect of knocking down REV3 expression was to completely offset the DDP resistance mediated by loss of MMR. Knockdown of REV3 also reduced the mutagenicity of DDP and eliminated the enhanced mutagenicity of DDP observed in the MMR−/REV3+ cells. Similar results were obtained when the ability of the cells to express luciferase from a platinated plasmid was measured. We conclude that Pol ζ plays a central role in the mutagenic bypass of DDP adducts and that the DDP resistance, enhanced mutagenicity, and the increased capacity of MMR−/REV3+ cells to express a gene burdened by DDP adducts are all dependent on the Pol ζ pathway.</jats:p> |
doi_str_mv | 10.1158/1078-0432.ccr-05-1380 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDc4LTA0MzIuY2NyLTA1LTEzODA |
imprint | American Association for Cancer Research (AACR), 2006 |
imprint_str_mv | American Association for Cancer Research (AACR), 2006 |
institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
issn | 1078-0432, 1557-3265 |
issn_str_mv | 1078-0432, 1557-3265 |
language | English |
last_indexed | 2024-03-01T16:04:51.937Z |
match_str | lin2006dnapolymerasezaccountsforthereducedcytotoxicityandenhancedmutagenicityofcisplatininhumancoloncarcinomacellsthathavelostdnamismatchrepair |
mega_collection | American Association for Cancer Research (AACR) (CrossRef) |
physical | 563-568 |
publishDate | 2006 |
publishDateSort | 2006 |
publisher | American Association for Cancer Research (AACR) |
record_format | ai |
recordtype | ai |
series | Clinical Cancer Research |
source_id | 49 |
spelling | Lin, Xinjian Trang, Julie Okuda, Tsuyoshi Howell, Stephen B. 1078-0432 1557-3265 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1078-0432.ccr-05-1380 <jats:title>Abstract</jats:title> <jats:p>The mutagenicity of cis-diamminedichloroplatinum(II) (DDP; cisplatin) and the rate at which resistance develops with repeated exposure to DDP are dependent on mutagenic translesional replication across DDP DNA adducts, mediated in part by DNA polymerase ζ, and on the integrity of the DNA mismatch repair (MMR) system. The aim of this study was to determine whether disabling Pol ζ by suppressing expression of its hREV3 subunit in human cancer cells can reduce the mutagenicity of DDP and whether loss of MMR facilitates mutagenic Pol ζ-dependent translesional bypass. The HCT116+ch3 (MMR+/REV3+) and HCT116 (MMR−/REV3+) human colon carcinoma cell lines were engineered to suppress hREV3 mRNA by stable expression of a short hairpin interfering RNA targeted to hREV3. The effect of knocking down REV3 expression was to completely offset the DDP resistance mediated by loss of MMR. Knockdown of REV3 also reduced the mutagenicity of DDP and eliminated the enhanced mutagenicity of DDP observed in the MMR−/REV3+ cells. Similar results were obtained when the ability of the cells to express luciferase from a platinated plasmid was measured. We conclude that Pol ζ plays a central role in the mutagenic bypass of DDP adducts and that the DDP resistance, enhanced mutagenicity, and the increased capacity of MMR−/REV3+ cells to express a gene burdened by DDP adducts are all dependent on the Pol ζ pathway.</jats:p> DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair Clinical Cancer Research |
spellingShingle | Lin, Xinjian, Trang, Julie, Okuda, Tsuyoshi, Howell, Stephen B., Clinical Cancer Research, DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair, Cancer Research, Oncology |
title | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_full | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_fullStr | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_full_unstemmed | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_short | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
title_sort | dna polymerase ζ accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost dna mismatch repair |
title_unstemmed | DNA Polymerase ζ Accounts for the Reduced Cytotoxicity and Enhanced Mutagenicity of Cisplatin in Human Colon Carcinoma Cells That Have Lost DNA Mismatch Repair |
topic | Cancer Research, Oncology |
url | http://dx.doi.org/10.1158/1078-0432.ccr-05-1380 |